COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,629 Articles (22,913 medRxiv, 8,716 bioRxiv)

Most recent first Previous |  Page 1948: Articles 19471-19480  | Next

A two-phase stochastic dynamic model for COVID-19 mid-term policy recommendations in Greece: a pathway towards mass vaccination
Rachaniotis, N. P., Dasaklis, T. K., Fotopoulos, F., Tinios, P.
10.1101/2021.01.07.21249394 — Posted: 2021-01-08
Timeliness of U.S. mortality data releases during the COVID-19 pandemic: delays are associated with electronic death registration system and elevated weekly mortality
Rosenbaum, J. E., Stillo, M., Graves, N., Rivera, R.
10.1101/2021.01.07.21249401 — Posted: 2021-01-08
Epidemiological differences in the impact of COVID-19 vaccination in the United States and China
Makhoul, M., Chemaitelly, H., Ayoub, H. H., Seedat, S., Abu-Raddad, L. J.
10.1101/2021.01.07.21249380 — Posted: 2021-01-08
Competing Health Risks Associated with the COVID-19 Pandemic and Response: A Scoping Review
Baral, S. D., Rao, A., Twahirwa Rwema, J. O., Lyons, C., Cevik, M., Kagsten, A. E., Diouf, D., Sohn, A. H., Phaswana-Mafuya, R., Kamarulzaman, A., Millett, G., Marcus, J. L., Mishra, S.
10.1101/2021.01.07.21249419 — Posted: 2021-01-08
Predicting severity of Covid-19 using standard laboratory parameters
Buchmueller, T., Groening, I., Ihl, R.
10.1101/2021.01.07.21249392 — Posted: 2021-01-08
Comparing the age and sex trajectories of SARS-CoV-2 morbidity with other respiratory pathogens points to potential immune mechanisms.
Metcalf, C. J. E., Paireau, J., ODriscoll, M., Pivette, M., Hubert, B., Pontais, I., Cummings, D., Cauchemez, S., Salje, H.
10.1101/2021.01.07.21249381 — Posted: 2021-01-08
Ultrasensitive RNA biosensors for SARS-CoV-2 detection in a simple color and luminescence assay
Chakravarthy, A., N, A. K., George, G., Ranganathan, S., Shettigar, N., U, S., Palakodeti, D., Gulyani, A., Ramesh, A.
10.1101/2021.01.08.21249426 — Posted: 2021-01-08 Discussion: Onsite | Offsite
High prevalence of long-term psychophysical olfactory dysfunction in patients with COVID-19
Boscolo-Rizzo, P., Menegaldo, A., Fabbris, C., Spinato, G., Borsetto, D., Vaira, L. A., Calvanese, L., Pettorelli, A., Sonego, M., Frezza, D., Bertolin, A., Cestaro, W., Rigoli, R., Tirelli, G., Da Mosto, M. C., Menini, A., Polesel, J., Hopkins, C.
10.1101/2021.01.07.21249406 — Posted: 2021-01-08
Analysis of Intervention Effectiveness Using Early Outbreak Transmission Dynamics to Guide Future Pandemic Management and Decision-Making in Kuwait
Tyshenko, M. G., Oraby, T., Longenecker, J. C., Vainio, H., Gasana, J., Alali, W., AlSeaidan, M., Elsaadany, S., Al-Zoughool, M.
10.1101/2021.01.07.21249409 — Posted: 2021-01-08
Findings from Cardiovascular Evaluation of NCAA Division I Collegiate Student-Athletes after Asymptomatic or Mildly Symptomatic SARS-CoV-2 Infection
Hwang, C. E., Kussman, A., Christle, J. W., Froelicher, V., Wheeler, M. T., Moneghetti, K. J.
10.1101/2021.01.07.21249407 — Posted: 2021-01-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).